How much diagnostics in patients with pancreatic cancer?;Wie viel diagnostik ist beim pankreaskarzinom nötig?

Zentralblatt fur Chirurgie

Volumn 128, Issue 5, 2003, Pages 368-374

  Bosseckert, H ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Differentation to mass forming pancreatitis; Early diagnosis; Pancreatic cancer; Staging

Indexed keywords

CANCER PATIENT; CANCER STAGING; CHRONIC PANCREATITIS; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; HUMAN; NEEDLE BIOPSY; PANCREAS BIOPSY; PANCREAS CANCER; REVIEW;

BIOPSY; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; HUMANS; LAPAROSCOPY; MAGNETIC RESONANCE IMAGING; MEDICAL HISTORY TAKING; META-ANALYSIS; NEOPLASM STAGING; PANCREAS; PANCREATIC FUNCTION TESTS; PANCREATIC NEOPLASMS; PANCREATITIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0038544282     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40029     Document Type: Review

References (48)

1. Adamek HE, Albert J, Breer H, Weitz M, Schilling D, Riemann JF. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet 2000; 356: 190-193
2. Azuma T, Yamada M, Hori H, Murakita H, Nishikawa K, Kohli Y, Taggart RT. Cancer specific expression of cathepsin E in pancreatic ductal cells. DDW 1994, New Orleans, Abstr. 73b
3. Berberat P, Friess H, Kashiwagi M, Beger HG. Diagnosis and staging of pancreatic cancer by positron emission tomography. World J Surg 1999; 23: 882-887
4. Birk D, Fortnagel G, Formentini A, Beger HG. Small carcinoma of the pancreas. Factors of prognostic relevance. J Hepatobiliary Pancreat 1998; 5: 450-454
5. Bodner E, Glaser K. Intraoperative needle aspiration and biopsy. In: Trede M, Carter DC (Hrsg). Surgery of the pancreas. Churchill Livingstone, Edinburgh, New York 181-186
6. Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB. Early diagnosis and treatment of panreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999; 131: 247-255
7. Boyle P, Maisonneuve P, Bucno de Mesquita B, Ghadirian P, Howe GR, Zatonski W, Baghurst P, Moerman CJ, Simard A, Miller AB, Przewozniak K, McMichael AJ, Hsieh CC, Walker AM. Cigarette smoking and pancreas cancer: a case-control study of the SEARCH programme of the IARC. Int J Cancer 1996; 67: 63-71
8. 18F-Fluorodeoxyglucose-Positron-Emission tomography with preoperative evaluation of patients with panreatic masses. Pancreas 2000; 20: 109-116
9. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40-years' observations on male British doctors. BMJ 1994; 309: 901-911
10. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis. JAMA 1995; 273: 1605-1609
11. Fuchs CS, Colditz GA, Stampfer JM, Giovanucci EL, Hunter DJ, Rimm EB, Willett WC, Speizer FE. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 1996; 156: 2255-2260
12. Fukushige S, Furukawa T, Satoh K et al. Loss of chromosome 18q is an early event in pancreatic ductaltumourigenesis. Cancer Res 1998, 58: 4222-4226
13. Gaa J, Richter A, Lorenz D, Post S, Georgi M, Trede M. Kernspintomographische Diagnostik von Pankreastumoren. Deutsches Årzteblatt 2001; 98: 330-332
14. Gates LK Jr, Holladay DV. A syndrome of hereditary pancreatic adenocarcinoma and cysts of the liver and kidneys. Gastroenterology 2002; 122: 796-799
15. Griffanti-Bartoli F, Arnone GB, Ceppa P, Ravera G, Carrabetta S, Civalleri D. Malignant tumours in the head of the pancreas and the periampullary region. Diagnostic and prognostic aspects. Anticancer Res 1994; 14: 657-666
16. Gullo L, Migliori PTM, Casadei R, Marrano D. Do early symptoms of pancreas cancer exist that can allow an earlier diagnosis? Pancreas 2001; 22: 210-213
17. Gullo L, Ancona D, Pezilli R, Casadei R, Campione O. Glucose tolerance and insulin secretion in pancreatic cancer. Ital J Gastroenterol 1993; 25: 487-489
18. Ishikawa O, Ohigashi H, Imaoka S, Nakaizumi A, Uehara H, Kitamura T, Kuroda C. Minute carcinoma of the pancreas measuring 1 cm or less in diameter - collective review of Japanese case reports. Hepato-Gastroenterology 1999; 46: 8-15
19. Ito T, Ino Y, Ishibashi T, Inoue M, Arita Y, Nawata H. Differential Diagnosis of tumor-forming pancreatitis and pancreatic cancer based on measures of endocrine and exocrine pancreatic functions. Pancreas 2002; 25: 7 (Abstr.)
20. Jimenez RE, Warshaw AL, Castillo CF. Laparoscopy and peritoneal cytology in the staging of pancreatic cancer. J Hepatobiliary Pancreas Surg 2000; 7: 15-20
21. Johanson IF, Eisen GM. Pancreatic cancer. In: Johanson (Hrsg). Gastrointestinal diseases: risk factors and prevention. Lippincott-Raven, Philadelphia 1977; 255-263
22. Kawa S, Tokoo M, Haseba O et al. Comparative study of CA 242 and CA 19-9 for the diagnosis of pancreatic cancer. Br J Cancer 1994; 70: 481-486
23. Keogan MT, Tyler D, Clark L et al. Diagnosis of pancreatic carcinoma: role of FDG PET. Am J Roentgenol 1998; 171: 1565-1570
24. Kodama T, Koshitani T, Sato H, Imamura Y, Kato K, Abe M, Wakabayashi N, Tatsumi Y, Horii Y, Yamane Y, Yamagishi H. Electronic pancreatoscopy for the diagnosis of pancreatic diseases. Am J Gastroenterlogy 2002; 97: 617-622
25. Kusama T, Mukai M, Iwasaki T, Tatsuta M, Matsumoto Y, Akedo H, Inoue M, Nakamura H. 3-Hydroxy-3-Methylglutaryl-Coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis. Gastroenterology 2002; 122: 308-317
26. La Vecchia C, Negri E. Fats in seasoning and the relationship to pancreatic cancer. Eur J Cancer Prev 1997; 6: 370-373
27. Lundin J, Roberts PJ, Kuuela P et al. Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9. Anticancer Res 1995; 15: 2181-2186
28. Matsubayashi H, Watanabe H, Ajioka Y, Nishikura K, Yamano M, Seki T, Saito T. Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis. Pancreas 2000; 21: 77-85
29. Matsuno S, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, Katoh H, Okade S, Suda K, Nakao A, Isaji S, Hiraoka T, Hosotani R, Imaizumi T. Pancreatic cancer: current status of treatment and survival of 16071 patients diagnosed from 1981-1996, using the Japanese National Pancreatic Cancer Database. Int J Clin Oncol 2000; 1985: 153-157
30. Meining A, Dittler HJ, Wolf A, Lorenz R, Schusdziarra V, Siewert JR, Classen M, Höfler H, Rösch T. You get what you expect? A critical appraisal of imaging methodology in endosonographic cancer staging. Gut 2002; 50: 599-603
31. Mertz HR, Sechopoulos P, Delbeke D, Leach SD. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 2000; 52: 367-371
32. Palumbo KS, Wands JR, Safran H, King T, Carlson RI, de la Monte S. Human Aspartyl (Asparaginyl) β-Hydroxylase Monoclonal antibodies: potential biomarkers for pancreatic carcinoma. Pancreas 2002; 25: 39-44
33. Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnquist HJ, Larson J. Pancreatic cancer is associated with glucose metabolism. Eur J Surg 1993; 59: 101-107
34. Pietrabissa A, Caramella D, Di Candio G, Carobbi A, Boggi U, Rossi G, Mosca F. Laparoscopy and laparoscopic ultrasonography for staging pancreatic cancer: critical appraisal. World J Surg 1999; 23: 998-1003
35. Reske SN. Positronen-Emissions-Tomographie in der Onkologie. Dtsch Årztebl 1998; 35: B1495-1497
36. Rode JD, Thorban S, Pantel K, Siewert JR. Micrometastases in bone marrow: prognostic indicators for pancreatic cancer. World J Surg 1999; 23: 888-891
37. Rösch TH, Lorenz R, Braig CH, Feuerbach S, Siewert JR, Classen M. Endosonographische Diagnostik bei Pankreastumoren. Dtsch med Wschr 1990; 115: 1339-1347
38. Sahai AV, Devonshire D, Yeoh KG, Kay C, Feldman D, Willner I, Farber J, Patel R, Tarnasky PR, Cunningham JT, Trus T, Hawes RH, Cotton PB. The decision-making value of magnetic resonance cholangiopancreatography in patients seen in a referral center for suspected biliary and pancreatic disease. Am J Gastroenterol 2001; 96: 2074-2080
39. Schoefer M, Klein S, Weber CH, Scharnke WH, Ackermann H, Dancygier H. Detecting ampullary and pancreatic tumors: comparison of endosopic ultrasound, magnetic rosonance imaging, computer tomography and transabdominal ultrasound. Gastroenterology 2000; 118: A268
40. Schramm H, Urban H, Penzlin G, Bosseckert H. Intrasurgical pancreas cytology. Pancreas 2001; 24: 210-214
41. Sheridan MB, Ward J, Guthrie JA et al. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis. Am J Roentgenol 1999; 173: 583-590
42. Tanaka N, Okada S, Ueno H, Okusaka T, Ikeda M. The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer. Pancreas 2000; 4: 378-381
43. Tsuchiya R, Noda T, Harada N, Miyamoto S, Tomioka T, Yamamoto K, Yamaguchi T, Izawa K, Tsunoda T, Yoshino R. Collective review of small carcinomas of the pancreas. Ann Surg 1986; 203: 77-81
44. Tsukasa T, Yamamoto Y, Kimoto M, Imai H, Iwamoto S, Kawasaki S, Kawashima K, Tadaoka Y, Majima T, Onuma E, Iki K, Kubozoe T, Ero T. Staging and treatment for patients with pancreatic cancer. How small is an early pancreatic cancer? J Hep Bil Pancr Surg 1998; 5: 128-132
45. Urgell E, Puig P, Boadas J, Capella G, Queralto JM, Boluda R, Antonijuan A, Farré A, Lluís F, González-Sastre F, Mora J. Prospective evaluation of the contribution of K-ras mutational analysis and CA 19-9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer. Eur J Cancer 2000; 36: 2069-2075
46. Watanabe H, Sawabu N, Songür Y, Yamaguchi Y, Yamakawa O, Satomura Y, Ohta H, Motoo Y, Okai T, Wakabayashi T. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis. Pancreas 1996; 12: 18-24
47. Watanabe H, Ha A, Hu YX, Ohtsubo K, Yamaguchi Y, Motoo Y, Okai T, Toya D, Tanaka N, Sawabu N. K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma. Cancer 1999; 86: 1441-1448
48. Whitemore AS, Paffenbarger RS Jr, Anderson K, Halpern J. Early precursors of pancreatic cancer in college men. J Chronic Dis 1983; 36: 251-256